If You Invested in Costas Inc (CSSI)
Looking for the current price? See the CSSI quote & overviewWhat $1,000 or $10,000 in CSSI Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 29, 2015 |
|---|---|---|---|---|
| $1,000 | — | $362 -64% | $36 -96% | $17 -98% |
| $10,000 | — | $3,621 -64% | $359 -96% | $168 -98% |
Based on real historical closing prices, dividend- and split-adjusted, through 2025-03-13. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CSSI$1,000 Investment Over Time
CSSI vs S&P 500Year-by-Year Returns
CSSI annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2016 | $12.20 | $0.80 | -93.4% | -93.4% |
| 2017 | $0.80 | $4.00 | +400.0% | -67.2% |
| 2018 | $5.00 | $3.40 | -32.0% | -72.1% |
| 2019 | $3.80 | $1.80 | -52.6% | -85.2% |
| 2020 | $1.40 | $0.50 | -64.3% | -95.9% |
| 2021 | $0.25 | $0.68 | +172.0% | -94.4% |
| 2022 | $0.68 | $0.0610 | -91.0% | -99.5% |
| 2023 | $0.0620 | $0.5740 | +825.8% | -95.3% |
| 2024 | $0.5740 | $0.2785 | -51.5% | -97.7% |
| 2025 | $0.3370 | $0.0840 | -75.1% | -99.3% |
About Costas Inc
OTC
CSSI historically referred to Costas, Inc., an over-the-counter company that has done business as Standard Dental Labs Inc. (SDL) in the dental laboratory and dental prosthetics sector. According to multiple company press releases, Costas, Inc. shifted its focus to the dental lab industry by acquiring the Standard Dental Labs business model and related intellectual property, and by pursuing acquisitions of privately owned dental laboratories.
In April 2024, Costas, Inc. described itself as the parent company of Standard Dental Labs Inc., a dental lab headquartered in Orlando, Florida. Standard Dental Labs operates in the dental lab segment, with an emphasis on dental restorations and prosthetics and on serving dental professionals. Earlier disclosures note that the company’s profits have stemmed from manufacturing dental implants, dental prosthetics, and other dental lab services and products.
Over time, the company articulated a growth-through-acquisition model. Press releases state that Standard Dental Labs aims to acquire independent, privately owned dental labs, particularly in Florida and other North American markets with populations over one million. The strategy involves consolidating acquired labs into a regionally central facility, sometimes referred to by the company as a larger or “mega” lab, with the goal of adding incremental revenue and achieving operational efficiencies.
Company communications highlight several themes: consolidation in the dental lab industry, the retirement of baby boomer dental lab owners without succession plans, and the opportunity to acquire labs from owners seeking an exit or retirement. Standard Dental Labs has also promoted a retirement succession program that allows dental lab owners to sell their businesses to the company while seeking to preserve the labs’ legacy and provide financial outcomes for sellers.
In addition to operational plans, the company has emphasized regulatory and reporting milestones. It has referenced the filing of annual reports, the engagement of auditors, the filing of a registration statement on Form S-1, and work toward or with FINRA and SEC compliance. A Canadian cease trade order affecting the company was reported as rescinded, and the company has also discussed using a Tier 2 Regulation A offering to raise capital for expansion in Florida’s dental lab market.
From a corporate identity standpoint, a March 2025 press release announced that the Financial Industry Regulatory Authority processed a name change from Costas, Inc. to Standard Dental Labs Inc. and a corresponding ticker symbol change from CSSI to TUTH, with an interim period in which the stock trades under CSSID following a reverse stock split. That disclosure indicates that the CSSI symbol represents the company’s historical trading identity, while TUTH is expected to be the ongoing symbol after the transition period.
Throughout these communications, the company positions itself within the dental prosthetics and dental laboratory sector, with operations and acquisition activity focused on Florida and a broader stated target of North American markets. Its business description centers on discovering, acquiring, and developing dental labs, consolidating them into central facilities, and providing dental lab products and services to dental professionals.
Business model and operations
According to its public statements, the company’s business model combines operating dental lab facilities with acquiring additional labs. Revenue has been described as coming from manufacturing dental implants, dental prosthetics, and related dental lab services and products. The company has indicated that acquired labs are intended to continue operating under a consolidated structure, contributing to the company’s income statement.
Standard Dental Labs has also highlighted investments in equipment and tooling, including upgrades to 3D milling equipment, medical-grade compressors, and air filtration systems, which it associates with improved precision, production capacity, and workplace air quality for lab technicians. These investments are framed as part of its approach to automation and operational efficiency within the dental prosthetics industry.
Corporate evolution and ticker change
The company’s own disclosures describe a multi-step evolution: acquisition of the Standard Dental Labs business model and assets, establishment of headquarters in Orlando, Florida, acquisition of at least one lab (Prime Dental Lab), and then a formal rebranding. In March 2025, a press release stated that the company’s official name changed from Costas, Inc. to Standard Dental Labs Inc., with a ticker change from CSSI to TUTH and a period of trading under CSSID following a 20-for-1 reverse stock split.
For investors and researchers, this means that historical information about the company’s activities in the dental lab sector is associated with the CSSI symbol and the Costas, Inc. name, while more recent references may appear under the Standard Dental Labs Inc. name and, after the transition period, under the TUTH ticker.
Geographic focus
Company releases repeatedly emphasize Florida, and specifically Orlando, as a core operating area. The company has described itself as headquartered in Orlando, Florida, and has discussed acquiring and consolidating labs in the Orlando area. It has also stated that all North American markets with populations over one million are targets for its acquisition strategy, indicating an intended geographic reach beyond Florida, while still highlighting Florida’s growing dental sector as a key focus.
Industry context as described by the company
In its own commentary, the company notes that the dental lab industry in the United States is fragmented and that consolidation can create economies of scale. It cites industry estimates that dental labs across the United States collectively generate significant annual revenue and points to consolidation trends in related healthcare sectors, such as dental and medical clinics, as a model for its acquisition-based growth approach.
Status of CSSI symbol
Based on the March 2025 announcement, CSSI is best understood as the company’s former ticker symbol associated with the Costas, Inc. name. The same announcement explains that the company rebranded to Standard Dental Labs Inc. and that its stock is expected to trade under CSSID for a limited period before transitioning to TUTH. Users researching CSSI are therefore viewing the historical identity and disclosures of the company prior to and during this transition.
FAQs about CSSI / Costas, Inc. / Standard Dental Labs Inc.
Frequently Asked Questions
Costas Inc investment returns
How much would $1,000 invested in Costas Inc be worth today?
If you invested $1,000 in Costas Inc (CSSI) 10 years ago on 2016-07-28, your investment would be worth $36 as of 2025-03-13, representing a -96.4% total return, growing at a compounded rate of -32.0% per year (CAGR).
Has Costas Inc outperformed the S&P 500?
Over the past 10 years, CSSI returned -96.4% compared to +291.0% for the S&P 500, underperforming the benchmark by 387.4 percentage points.
What is Costas Inc's average annual return?
The compound annual growth rate (CAGR) of CSSI over the past 10 years is -32.0%, growing at a compounded rate each year. Individual years vary significantly — CSSI's best recent year was 2023 (+825.8%) and worst was 2016 (-93.4%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
